Mudd TW, Diebold K, Parks K, Hardee M, et al. Outcomes with intensive chemotherapy, compared to hypomethylating agent + venetoclax, in patients with intermediate and adverse risk acute myeloid leukemia. Leuk Res 2025;156:107920.
PMID: 40714675